Literature DB >> 25726571

Factors determining non-compliance to mass drug administration for lymphatic filariasis elimination in endemic districts of Nepal.

R K Adhikari, J B Sherchand, S R Mishra, K Ranabhat, P Devkota, D Mishra, Y C Ghimire, K Gelal, R Mishra, R Paudel, R R Wagle.   

Abstract

BACKGROUND: Mass drug administration (MDA) has been implemented in Nepal since 2003 for elimination of Lymphatic Filariasis (LF). The objective of this study was to explore the factors that determine the non-compliance to MDA for Lymphatic Filariasis elimination in endemic districts of Nepal.
METHODS: A cross-sectional descriptive study was carried out in three endemic districts namely Dhading, Kapilvastu and Kailali. A total of 900 people were interviewed with structured questionnaire.
RESULTS: The result shows that the respondents who knew the DEC contains Albendazole (84.9% vs 42.5%, P<0.001, Adjusted OR=2.89(1.946-4.29) at 95% CI), who were aware of MDA campaign (78.2% vs 33.8% P<0.001, Adjusted OR=2.87(1.73-4.74) at 95% CI), who were visited by health workers at their home during MDA campaign (75.9% vs 24.1% P<0.001, Adjusted OR=4.85(2.448-9.594) at 95% CI) had significantly higher compliance. The respondents who had knowledge of side effects during MDA campaign had lower prevalence of non-compliance as compared who did not have (9.4% vs 33.2%, P<0.001).
CONCLUSIONS: Advanced age, primary or below education, ever married, inadequate knowledge on drug, inadequate awareness on MDA, no home visit by health workers during MDA, no belief on MDA drugs were significantly associated with higher non-compliance to MDA. In future, MDA program should focus on awareness campaigns related to composition of drugs, side effects of drugs and compulsory home visit during the campaign.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25726571

Source DB:  PubMed          Journal:  J Nepal Health Res Counc        ISSN: 1727-5482


  7 in total

1.  Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.

Authors:  Alison Krentel; Rita Damayanti; Christiana Rialine Titaley; Nugroho Suharno; Mark Bradley; Timothy Lynam
Journal:  PLoS Negl Trop Dis       Date:  2016-11-03

2.  Perceived threat and benefit toward community compliance of filariasis' mass drug administration in Pekalongan district, Indonesia.

Authors:  Bagoes Widjanarko; Lintang Dian Saraswati; Praba Ginandjar
Journal:  Risk Manag Healthc Policy       Date:  2018-10-23

3.  Feasibility of school-based health education intervention to improve the compliance to mass drug administration for lymphatic Filariasis in Lalitpur district, Nepal: A mixed methods among students, teachers and health program manager.

Authors:  Prativa Karki; Yayi Suryo Prabandari; Ari Probandari; Megha Raj Banjara
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

Review 4.  Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review.

Authors:  Ahmad Farid Nazmi Abdul Halim; Dzulfitree Ahmad; Jane Ling Miaw Yn; Noor Azreen Masdor; Nurfatehar Ramly; Rahayu Othman; Thinakaran Kandayah; Mohd Rohaizat Hassan; Rahmat Dapari
Journal:  Int J Environ Res Public Health       Date:  2022-10-10       Impact factor: 4.614

5.  Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.

Authors:  Chet Raj Ojha; Basant Joshi; Khagendra Prakash Kc; Shyam Prakash Dumre; Keshav Kumar Yogi; Bandana Bhatta; Tulasi Adhikari; Kathryn Crowley; Babu Ram Marasini
Journal:  PLoS Negl Trop Dis       Date:  2017-07-19

6.  Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.

Authors:  Alfred Kwesi Manyeh; Latifat Ibisomi; Rohit Ramaswamy; Frank Baiden; Tobias Chirwa
Journal:  PLoS Negl Trop Dis       Date:  2020-08-17

7.  Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.

Authors:  Christabel Khaemba; Abbie Barry; Wyckliff P Omondi; Kefa Bota; Sultani Matendechero; Cecilia Wandera; Fred Siyoi; Elvis Kirui; Margaret Oluka; Pamela Nambwa; Parthasarathi Gurumurthy; Sammy M Njenga; Anastacia Guantai; Eleni Aklillu
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.